Trial intelligence / Profile preview

Rec-LH Luteal Supplementation in IVF with GnRH-agonist Trigger

NCT00954811Phase 4Unknown

Sponsor
UZ Brussel
Start
Sep 2005
Primary completion
Jan 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by UZ Brussel. Primary endpoints: Pregnancy occurrence and Pregnancy loss. Status: unknown.

02

Drugs

lutropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT00954811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00954811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call